The effect of myo-inositol supplementation on NAFLD
- Conditions
- non-alcoholic fatty liver.Fatty (change of) liver, not elsewhere classifiedK76.0
- Registration Number
- IRCT20190724044322N2
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 44
Age 18-55 years
Body mass index in the range of 30-40 Kg / m2
Willingness to cooperate
Hepatic steatosis based on Grade 1 and 2 NAFLD disease
Athlete, pregnancy, lactation and menopause in women
Infertility treatment, taking oral contraceptive pills
Smoking and alcohol use
Adherence to a special diet 3 months before the study
Use of chemical or herbal medicines for weight loss and use of hepatotoxic drugs such as phenytoin, amoxifine , lithium and insulin sensitizer medications, antibiotics or any kind of supplements that may affect liver enzymes
History of weight loss surgery over the last year or rigid weight loss diets three months before the trial
Use of NSAIDs or any any multivitamin or supplements for 3 months before or during the study
those with cardiovascular disease, hepatic, renal, intestinal, thyroid and parathyroid dysfunction, billiary disease, known autoimmune diseases, PCOs, cancers and conditions
use of any antihypertensive drugs and lipid-lowering drugs (statins) and medications related to cardiovascular patients
Candidate or history of Liver transplant
Intention for pregnancy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method